In summary, our results provide novel evidence that epigenetic modifications of LIMD1-AS1 are mediated by CDK7-activated interferon pathways by directly binding HSPA5, which might contribute to glioma progression. This evidence concerns the gene HSPA5 and central nervous system cancer.